Risk Of Developing Liver Cancer After HCV Treatment

Monday, April 21, 2014

Advances in Chronic Hepatitis C Management and Treatment - EASL 1.5-hour Internet symposium


When new education-related information on hepatitis is released online this blog provides background information and links to the new activity.   

ViralEd just released an 1.5-hour Internet symposium discussing key data presented at the 49th Annual Meeting of the European Association for the Study of the Liver (49th EASL) which took place this month in London, England.

Advances in Chronic Hepatitis C Management and Treatment

Highlights
HCV Therapies In Treatment Naive Patients
HCV Therapies In Treatment Experienced Patients 
Studies In HIV/HCV Co-Infection and Other Public Health Issues

Like any site offering continuing medical education (CME), it requires a free quick registration.

1- When prompted type in your name and email address
2- Click "Go To Program"

Be patient, depending on your Internet connection it may take a few moments to load.

 CLICK HERE TO BEGIN

Faculty
Nezam H. Afdhal, MD
Professor of Medicine
Harvard School of Medicine
Chief of Hepatology, Director of Liver Center
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Fred Poordad, MD
VP, Academic and Clinical Affairs
The Texas Liver Institute
Clinical Professor of Medicine
University of Texas Health Science Center
San Antonio, Texas

K. Rajender Reddy, MD
Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director, Viral Hepatitis Center
University of Pennsylvania
Philadelphia, Pennsylvania

No comments:

Post a Comment